Nuo Therapeutics, Inc. Stock Issued During Period, Value, Stock Options Exercised
New shares the company issued (share-based compensation, option exercises, employee stock purchase plans, new issues, acquisitions), as filed in its 10-Q and 10-K XBRL statement of shareholders' equity. This is the dilution side; Issuer Repurchases is the other side.
- Nuo Therapeutics, Inc. stock issued during period, value, stock options exercised for the quarter ending 2025-09-30 was $113.54K.
- Nuo Therapeutics, Inc. stock issued during period, value, stock options exercised for the quarter ending 2012-12-31 was $0.00.
- Nuo Therapeutics, Inc. stock issued during period, value, stock options exercised for the quarter ending 2012-09-30 was $9.98K.
- Nuo Therapeutics, Inc. stock issued during period, value, stock options exercised for fiscal 2025 was $113.54K, a 25.57% increase from fiscal 2024.
- Nuo Therapeutics, Inc. stock issued during period, value, stock options exercised for fiscal 2024 was $90.42K.
- Nuo Therapeutics, Inc. stock issued during period, value, stock options exercised for fiscal 2012 was $15.19K.
| Period end | Stock Issued During Period, Value, Stock Options Exercised 3 month | Stock Issued During Period, Value, Stock Options Exercised 12 month |
|---|---|---|
| 2025-12-31 | $113.54K 10-K · filed 2026-03-30 | |
| 2025-09-30 | $113.54K 10-Q · filed 2025-10-30 | |
| 2024-12-31 | $90.42K 10-K · filed 2026-03-30 | |
| 2012-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2013-03-18 | $15.19K 10-K · filed 2013-03-18 |
| 2012-09-30 | $9.98K derived: 10-Q 9 month − 10-Q 6 month · filed 2012-11-14 |